Document is current
Any future updates will be listed below
-
Authors
Kroenke, Mark A.
Milton, Mark N.
Kumar, Seema
Bame, Eris
White, Joleen T. https://orcid.org/0000-0001-5962-9047
- License Information
-
More Information
Article History
Received: 21 May 2021
Accepted: 23 August 2021
First Online: 5 November 2021
Declarations
:
: As HC-12 is a hypothetical case study, none of the authors have worked for a company developing this molecule. All authors have worked on immunogenicity risk assessments for other multi-specific molecules at current and/or previous employers.
